4 Life Sciences Tools & Services stocks are moving up in their overall rating this week, according to the Portfolio Grader database. Every one of these is graded an “A” (“strong buy”) or “B” overall (“buy”).
Bio-Techne Corporation’s (TECH) ratings are looking better this week, moving up to a B from last week’s C. Bio-Techne Corporation develops, manufactures, and sells biotechnology products and hematology calibrators and controls. For more information, get Portfolio Grader’s complete analysis of TECH stock.
Charles River Laboratories International, Inc. (CRL) is seeing ratings go up from a B last week to a A this week. Charles River Laboratories International, Inc. is a global provider of services to accelerate the drug discovery and development process. The company also gets A’s in return on equity. For more information, get Portfolio Grader’s complete analysis of CRL stock.
This week, PerkinElmer, Inc. (PKI) pushes up from a C to a B rating. PerkinElmer, Inc. provides technology, services and solutions to the diagnostics, research, environmental, industrial and laboratory services market. The company also gets A’s in operating margin growth and earnings growth. For more information, get Portfolio Grader’s complete analysis of PKI stock.
Cambrex Corporation (CBM) shows solid improvement this week. The company’s rating rises from a B to a A. Cambrex Corporation provides products and services intended to improve the discovery and commercialization of human therapeutics to global pharmaceutical and generic drug companies. The company also gets A’s in sales growth, earnings growth, earnings revisions, earnings surprise, and return on equity. For more information, get Portfolio Grader’s complete analysis of CBM stock.
Louis Navellier’s proprietary Portfolio Grader stock ranking system assesses roughly 5,000 companies every week based on a number of fundamental and quantitative measures. Stocks are given a letter grade based on their results — with A being “strong buy,” and F being “strong sell.” Explore the tool here.